Evidence — NAD+
supplement · asset evidence level: emerging
Evidence quality breakdown (linked documents)
expert_opinion: 7
Linked source documents (7)
- SS-31 — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- Sermorelin Acetate — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- Semax — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- NAD+ — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- Glutathione — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- Epitalon — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- NAD+ — Peptide Protocol Wiki reference (patient_education · expert_opinion)
Provider dosing references (Stage 9, source-attributed)
250-750 mg per IV session; 300-1000 mg daily for oral precursors (NR/NMN) — Peptide Protocol Wiki (peptideprotocolwiki.com)
Standard: 100 mg · Low: 50 mg · High: 200 mg — Peptide Dosing Protocols (peptidedosingprotocols.com)
Dosing claims (107) · Safety claims (22)
Extracted claims are provider-review scaffolding, stored verbatim with source attribution — not recommendations or dosing guidance.